Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

AstraZeneca PLC (GB:AZN)

LSE:AZN

UK Market

AZN

AstraZeneca

Analyst Forecasts

News & Insights

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Holding GB:AZN?

Track your performance easily

AstraZeneca (AZN) Stock News & Sentiment

556 Followers

AstraZeneca’s Calquence Wins FDA Approval for Mantle Cell Lymphoma

Market News

AstraZeneca’s Calquence Wins FDA Approval for Mantle Cell Lymphoma

20h ago

AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment

Company Announcements

AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment

1d ago

AstraZeneca Announces Share Capital and Voting Rights Update

Company Announcements

AstraZeneca Announces Share Capital and Voting Rights Update

16d ago

Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders

Class Action

Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders

22d ago

AstraZeneca Withdraws EU Application for Lung Cancer Drug

Company Announcements

AstraZeneca Withdraws EU Application for Lung Cancer Drug

25d ago

AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer

Company Announcements

AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer

26d ago

AstraZeneca Strengthens Board with New Non-Executive Director Appointments

Company Announcements

AstraZeneca Strengthens Board with New Non-Executive Director Appointments

1M ago

More GB:AZN News >

AZN News on the Web

2025-01-17

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

CNBC

Neutral

2025-01-17

COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth

Pharmaceutical Technology

Neutral

2025-01-17

AstraZeneca drug for rare blood cancer gets US regulatory green light

Proactive Investors

Neutral

2025-01-17

Kepler Capital Remains a Hold on AstraZeneca (AZN)

TipRanks News

Neutral

2025-01-15

JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year ahead

Pharmaceutical Technology

Neutral

2025-01-15

3 key reasons why AstraZeneca’s share price looks a steal to me right now

Fool.co.uk

Neutral

2025-01-13

These are my top 3 defensive shares to buy in 2025!

Fool.co.uk

Neutral

2025-01-13

AstraZeneca (AZN) Receives a Buy from Goldman Sachs

TipRanks News

Neutral

News Score - Last 7 Days

Neutral

GB:AZN

Sector Average

Media Buzz

This Week8 articles

Weekly Average5.75 articles

News Sentiment

This Week50%

Sector Average69%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:AZN’s Media Buzz Sentiment?

8 articles about GB:AZN were published this week. In an average week, 5.75 articles are published.

What is GB:AZN’s weekly average amount of articles?

In an average week, 5.75 articles about GB:AZN are published.

What is GB:AZN’s News Sentiment?

50% of articles about GB:AZN were positive this week, compared to its sector average of 69%.

Healthcare Stocks that are Trending in the News

FOLDAmicus

ATECAlphatec Holdings

APLSApellis Pharmaceuticals

BWAYBrainsway

RXSTRxSight

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing